Larvol Delta - March-Biosciences-Receives-FDA-Orphan-Drug-Designation-for-MB105-a-FirstinClass-CD5-CART-Cell-Therapy-for-TCell-Lymphoma

MB-105 - March Bio

https://www.globenewswire.com/news-release/2025/01/28/3016342/0/en/March-Biosciences-Receives-FDA-Orphan-Drug-Designation-for-MB-105-a-First-in-Class-CD5-CAR-T-Cell-Therapy-for-T-Cell-Lymphoma.html

Jan 28, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next